The role of miR-146a in dorsal root ganglia neurons of experimental diabetic peripheral neuropathy

Neuroscience

Volumn 259, Issue , 2014, Pages 155-163

  Wang, L ^a   Chopp, M ^a,b   Szalad, A ^a   Zhang, Y ^a   Wang, X ^a   Zhang, R L ^a   Liu, X S ^a   Jia, L ^a   Zhang, Z G ^a  

^a HENRY FORD HOSPITAL   (United States)

^b OAKLAND UNIVERSITY   (United States)

Author keywords

Diabetes; Mice; Mir 146a; Peripheral neuropathy; Sildenafil

Indexed keywords

INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; MICRORNA 146A; SILDENAFIL; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DORSAL ROOT GANGLION NEURON; DOWN REGULATION; EXPERIMENTAL DIABETIC NEUROPATHY; GENE EXPRESSION; GENE TARGETING; HYPERGLYCEMIA; IN VITRO STUDY; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SPINAL CORD NERVE CELL;

4′,6-DIAMIDINO-2-PHENYLINDOLE; A PHOSPHODIESTERASE TYPE 5; BKS.CG-M+/+LEPR(DB)/J; CDNA; COMPLEMENTARY DNA; DAPI; DB/DB; DB/M; DIABETES; DIG; DIGOXIN; DORSAL ROOT GANGLION; DRG; HETEROZYGOTE MICE; HG; HIGH GLUCOSE; INTERLEUKIN-1 RECEPTOR-ACTIVATED KINASE; IRAK1; LNA; LOCKED NUCLEIC ACID; MCID; MICE; MICRO COMPUTER IMAGING DEVICE; MICRORNA; MIR-146A; MIRNA; NG; NORMAL GLUCOSE; OCT; OPTIMAL CUTTING TEMPERATURE; PDE5; PERIPHERAL NEUROPATHY; RT-PCR; SALINE-SODIUM CITRATE; SILDENAFIL; SSC; STREPTOTOZIN; STZ; TDT-MEDIATED DUTP-BIOTIN NICK END LABELING; TLRS; TOLL-LIKE RECEPTORS; TRAF6; TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED FACTOR 6; TUNEL;

ANIMALS; CELLS, CULTURED; DIABETIC NEUROPATHIES; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GANGLIA, SPINAL; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; MALE; MICE; MICE, MUTANT STRAINS; MICRORNAS; NEURONS; PHOSPHODIESTERASE 5 INHIBITORS; PIPERAZINES; PURINES; RECEPTORS, LEPTIN; SULFONES; TNF RECEPTOR-ASSOCIATED FACTOR 6;

EID: 84891603945     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.11.057     Document Type: Article

References (42)

1. Acheampong E.A., Roschel C., Mukhtar M., Srinivasan A., Rafi M., Pomerantz R.J., Parveen Z. Combined effects of hyperglycemic conditions and HIV-1 Nef: a potential model for induced HIV neuropathogenesis. Virol. J. 2009, 6:183.
2. Akira S., Takeda K., Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001, 2:675-680.
3. Balasubramanyam M., Aravind S., Gokulakrishnan K., Prabu P., Sathishkumar C., Ranjani H., Mohan V. Impaired miR-146a expression links subclinical inflammation and insulin resistance in type 2 diabetes. Mol Cell Biochem 2011, 351:197-205.
4. Behm-Ansmant I., Rehwinkel J., Izaurralde E. MicroRNAs silence gene expression by repressing protein expression and/or by promoting mRNA decay. Cold Spring Harb Symp Quant Biol 2006, 71:523-530.
5. Cnop M., Welsh N., Jonas J.C., Jorns A., Lenzen S., Eizirik D.L. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 2005, 54(Suppl. 2):S97-S107.
6. Dahiya N., Sherman-Baust C.A., Wang T.L., Davidson B., Shih Ie M., Zhang Y., Wood W., Becker K.G., Morin P.J. MicroRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS ONE 2008, 3:e2436.
7. Dasu M.R., Devaraj S., Zhao L., Hwang D.H., Jialal I. High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes 2008, 57:3090-3098.
8. Dasu M.R., Devaraj S., Park S., Jialal I. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care 2010, 33:861-868.
9. Feldman E.L., Stevens M.J., Greene D.A. Pathogenesis of diabetic neuropathy. Clin Neurosci 1997, 4:365-370.
10. Feng B., Chen S., McArthur K., Wu Y., Sen S., Ding Q., Feldman R.D., Chakrabarti S. MiR-146a-mediated extracellular matrix protein production in chronic diabetes complications. Diabetes 2011, 60:2975-2984.
11. Heimberg H., Heremans Y., Jobin C., Leemans R., Cardozo A.K., Darville M., Eizirik D.L. Inhibition of cytokine-induced NF-kappaB activation by adenovirus-mediated expression of a NF-kappaB super-repressor prevents beta-cell apoptosis. Diabetes 2001, 50:2219-2224.
12. Hou J., Wang P., Lin L., Liu X., Ma F., An H., Wang Z., Cao X. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol 2009, 183:2150-2158.
13. Hua Y.J., Tu K., Tang Z.Y., Li Y.X., Xiao H.S. Comparison of normalization methods with microRNA microarray. Genomics 2008, 92:122-128.
14. Kantharidis P., Wang B., Carew R.M., Lan H.Y. Diabetes complications: the microRNA perspective. Diabetes 2011, 60:1832-1837.
15. Kishi M., Tanabe J., Schmelzer J.D., Low P.A. Morphometry of dorsal root ganglion in chronic experimental diabetic neuropathy. Diabetes 2002, 51:819-824.
16. Kusuda R., Cadetti F., Ravanelli M.I., Sousa T.A., Zanon S., De Lucca F.L., Lucas G. Differential expression of microRNAs in mouse pain models. Mol Pain 2011, 7:17.
17. Li X., Gibson G., Kim J.S., Kroin J., Xu S., van Wijnen A.J., Im H.J. MicroRNA-146a is linked to pain-related pathophysiology of osteoarthritis. Gene 2011, 480:34-41.
18. Liu Y., Ma Q. Generation of somatic sensory neuron diversity and implications on sensory coding. Curr Opin Neurobiol 2011, 21:52-60.
19. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
20. Melli G., Hoke A. Dorsal root ganglia sensory neuronal cultures: a tool for drug discovery for peripheral neuropathies. Expert Opin Drug Discov 2009, 4:1035-1045.
21. Nahid M.A., Satoh M., Chan E.K. Mechanistic role of microRNA-146a in endotoxin-induced differential cross-regulation of TLR signaling. J Immunol 2011, 186:1723-1734.
22. Natarajan R., Putta S., Kato M. MicroRNAs and diabetic complications. J Cardiovasc Transl Res 2012, 5:413-422.
23. Patapoutian A., Peier A.M., Story G.M., Viswanath V. ThermoTRP channels and beyond: mechanisms of temperature sensation. Nat Rev Neurosci 2003, 4:529-539.
24. Patapoutian A. Making the pain connection. Neuron 2001, 31:4-6.
25. Pickup J.C. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004, 27:813-823.
26. Russell J.W., Sullivan K.A., Windebank A.J., Herrmann D.N., Feldman E.L. Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol Dis 1999, 6:347-363.
27. Russell J.W., Golovoy D., Vincent A.M., Mahendru P., Olzmann J.A., Mentzer A., Feldman E.L. High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J 2002, 16:1738-1748.
28. Schmeichel A.M., Schmelzer J.D., Low P.A. Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes 2003, 52:165-171.
29. Schnare M., Barton G.M., Holt A.C., Takeda K., Akira S., Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001, 2:947-950.
30. Shi T.J., Zhang M.D., Zeberg H., Nilsson J., Grunler J., Liu S.X., Xiang Q., Persson J., Fried K.J., Catrina S.B., Watanabe M., Arhem P., Brismar K., Hokfelt T.G. Coenzyme Q10 prevents peripheral neuropathy and attenuates neuron loss in the db-/db- mouse, a type 2 diabetes model. Proc Natl Acad Sci U S A 2013, 110:690-695.
31. Taganov K.D., Boldin M.P., Chang K.J., Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 2006, 103:12481-12486.
32. Takeda K., Akira S. TLR signaling pathways. Semin Immunol 2004, 16:3-9.
33. Takeda K., Akira S. Toll-like receptors in innate immunity. Int Immunol 2005, 17:1-14.
34. Tamura T., Yanai H., Savitsky D., Taniguchi T. The IRF family transcription factors in immunity and oncogenesis. Annu Rev Immunol 2008, 26:535-584.
35. Vincent A.M., Olzmann J.A., Brownlee M., Sivitz W.I., Russell J.W. Uncoupling proteins prevent glucose-induced neuronal oxidative stress and programmed cell death. Diabetes 2004, 53:726-734.
36. Wang L., Zhang Z.G., Zhang R.L., Gregg S.R., Hozeska-Solgot A., LeTourneau Y., Wang Y., Chopp M. Matrix metalloproteinase 2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration. J Neurosci 2006, 26:5996-6003.
37. Wang L., Chopp M., Szalad A., Liu Z., Bolz M., Alvarez F.M., Lu M., Zhang L., Cui Y., Zhang R.L., Zhang Z.G. Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice. Neuroscience 2011, 193:399-410.
38. Xu J., Wu W., Zhang L., Dorset-Martin W., Morris M.W., Mitchell M.E., Liechty K.W. The role of microRNA-146a in the pathogenesis of the diabetic wound-healing impairment: correction with mesenchymal stem cell treatment. Diabetes 2012, 61:2906-2912.
39. Zhang Z., Davies K., Prostak J., Fenstermacher J., Chopp M. Quantitation of microvascular plasma perfusion and neuronal microtubule-associated protein in ischemic mouse brain by laser-scanning confocal microscopy. J Cereb Blood Flow Metab 1999, 19:68-78.
40. Zhang R.W.Y., Zhang L., Zhang Z., Tsang W., Lu M., Zhang L., Chopp M. Sildenafil (Viagra) induces neurogenesis and promotes functional recovery after stroke in rats. Stroke 2002, 33(11):2675-2680.
41. Zhao L., Mason N.A., Morrell N.W., Kojonazarov B., Sadykov A., Maripov A., Mirrakhimov M.M., Aldashev A., Wilkins M.R. Sildenafil inhibits hypoxia-induced pulmonary hypertension. Circulation 2001, 104:424-428.
42. Zochodne D.W., Verge V.M., Cheng C., Sun H., Johnston J. Does diabetes target ganglion neurones? Progressive sensory neurone involvement in long-term experimental diabetes. Brain 2001, 124:2319-2334.